首页|组蛋白乙酰转移酶P300和去乙酰化酶SIRT2在乳腺浸润性导管癌中的表达

组蛋白乙酰转移酶P300和去乙酰化酶SIRT2在乳腺浸润性导管癌中的表达

Expression of histone acetyltransferase P300 and deacetylase SIRT2 in breast invasive Ductal carcinoma

扫码查看
目的 探讨乳腺浸润性导管癌中组蛋白乙酰转移酶P300(P300)和去乙酰化酶SIRT2(SIRT2)的表达及其与临床病理特征的关系.方法 选取385例乳腺浸润性导管癌组织为病例组,36例癌旁组织为对照组,制成组织芯片,采用免疫组化En Vision二步法检测两组中P300和SIRT2的蛋白表达水平并比较其表达差异;分析病例组中P300和SIRT2蛋白水平与患者临床病理特征的关系,采用Spearman法分析乳腺癌患者中P300和SIRT2蛋白的相关性;采用Kaplan-Meier和Log rank test统计学方法分析P300和SIRT2蛋白与乳腺癌患者预后的关系.结果 病例组P300蛋白低表达率高于对照组、SIRT2蛋白低表达率低于对照组,差异有统计学意义(P<0.05);乳腺癌组织中,P300蛋白在肿瘤最大径>5 cm的低表达率高于≤5 cm、在TNM分期Ⅲ~Ⅳ期的低表达率高于Ⅰ~Ⅱ期、在有淋巴结转移的低表达率高于无淋巴结转移、在Ki67高表达的低表达率高于Ki67低表达、在LuminalB型中的低表达率高于三阴性乳腺癌(TNBC),差异有统计学意义(P<0.05);SIRT2蛋白在组织学分级3级中的低表达率低于1~2级、在肿瘤最大径>5 cm的低表达率高于≤5 cm、在Ki67高表达的低表达率低于Ki67低表达、在LuminalA型和LuminalB型中的低表达率低于HER2阳性型和TNBC,差异有统计学意义(P<0.05);P300和SIRT2蛋白的表达呈负相关(r=-1.77,P<0.001);P300蛋白低表达比高表达总体无病生存率低(P=0.046).结论 P300和SIRT2蛋白可能与乳腺浸润性导管癌的发生、发展相关,P300蛋白低表达可能提示乳腺浸润性导管癌患者预后较差.
Objective To investigate the expression of histone acetyltransferase P300 and deacetylase SIRT2 in breast invasive ductal carcinoma,and its relationship with clinicopathological features.Methods A total of 385 cases of breast invasive ductal carcinoma tissues as case group,36 precancerous tissues as control group.The tissue microarray was prepared,and the protein expression of P300 and SIRT2 in both groups was detected by immunohistochemical En Vision two-step method and then compared the expression differences.The relationship between P300 and SIRT2 protein and clinicopathological features of breast cancer patients was analyzed.The correlation between P300 and SIRT2 protein in patients with breast cancer was analyzed by Spearman method.Kaplan-Meier and Log rank test statistical methods were used to analyze the correlation between P300 and SIRT2 proteins and the prognosis of breast cancer patients.Results The low expression rate of P300 protein in the case group was higher than that of control group,and the low expression rate of SIRT2 protein was lower than that of control group,the difference was statistically significant(P<0.05).In breast cancer tissues,the low expression rate of P300 protein in tumor with maximum diameter>5 cm group was significantly higher than that of ≤5 cm group,the low expression rate in TNM stage Ⅲ-Ⅳ group was higher than that of stage Ⅰ-Ⅱ group,the low expression rate in lymph node metastasis group was higher than that of non-lymph node metastasis group,the low expression rate in Ki67 high expression group was higher than that of Ki67 low expression group,and the low expression rate in Luminal B type was higher than that of TNBC,the differences were statistically significant(P<0.05).The low expression rate of SIRT2 protein in histological 3 grading was lower than that of grade 1-2;the low expression rate in tumor with maximum diameter>5 cm group was higher than that of≤5 cm group,the low expression rate in Ki67 high expression group was lower than that of Ki67 low expression group,and the low expression rate in Luminal A type and Luminal B type was lower than that of HER2 positive type and TNBC,the differences were statistically significant(P<0.05).There was a negative correlation between the expression of P300 and SIRT2 protein(r=-1.77,P<0.001).The overall disease-free survival rate of the P300 protein low expression group was lower than that of the high expression group(P=0.046).Conclusions P300 and SIRT2 proteins might be related to the occurrence and development of breast invasive ductal carcinoma.Low expression of P300 protein might indicate poor prognosis in patients with breast invasive ductal carcinoma.

breast neoplasmsimmunohistochemistryP300 proteinSIRT2 proteinpathological featureshistone acetylation

段彦林、金柔、梅思思、田世维、黄玉鑫、徐澍

展开 >

贵州医科大学附属医院病理科,贵州贵阳 550004

黔南州中医医院病理科,贵州黔南 558000

乳腺肿瘤 免疫组化 P300蛋白 SIRT2蛋白 病理特征 组蛋白乙酰化

贵州省卫生健康委科学技术基金项目

gzwjkj2018-1-062

2024

贵州医科大学学报
贵阳医学院

贵州医科大学学报

CSTPCD
影响因子:0.827
ISSN:2096-8388
年,卷(期):2024.49(2)
  • 23